Study of radiomics based on dual-energy CT for nuclear grading and T-staging in renal clear cell carcinoma

Ning Wang,Xue Bing,Yuhan Li,Jian Yao,Zhengjun Dai,Dexin Yu,Aimei Ouyang
DOI: https://doi.org/10.1097/md.0000000000037288
IF: 1.6
2024-03-09
Medicine
Abstract:Clear cell renal cell carcinoma (ccRCC) is a type of malignant tumor originating from the urinary system, accounting for about 70%–85% of renal cell carcinoma, [ 1 ] and, it is the most lethal subtype with a high invasive potential. [ 2 ] The 5-year survival rate of patients with ccRCC is closely related with the pathological nuclear grade. [ 3 ] Patients with lower pathological nuclear grade of ccRCC have better prognosis and lower risk of recurrence than those with higher pathological nuclear grade. [ 4 , 5 ] Treatment of RCC includes radical resection, partial resection, tumor enucleation, as well as minimally invasive ablation and targeted therapy developed in recent years. Conservative surgery or minimally invasive ablation can be used for RCC with low pathological grade and staging, and active monitoring or targeted therapy can also be performed in some cases. [ 6 ] Tumor T-staging is a comprehensive assessment of tumor progression, and has great significance to the selection of treatment including surgical methods, the formulation of perioperative treatment plan and the prognosis of patients. Biopsy and histopathology are most commonly used for renal cancer grading and staging before operation. However, the disadvantages such as its inherent invasive, hysteresis, in vitro, and dependence on the accuracy puncture tissue limit its application.
medicine, general & internal
What problem does this paper attempt to address?